Results 191 to 200 of about 94,246 (299)
ABSTRACT This systematic review and meta‐analysis of randomized controlled trials (RCTs) was conducted to assess the effect of nutraceuticals containing Citrus bergamia on the management of obesity in adults by assessing measures related to obesity. We searched the following databases until October 2024: PubMed, Web of Science, Scopus, and the Cochrane
Carmelo Pujia +8 more
wiley +1 more source
ABSTRACT People living with obesity and obesity‐related complications who are experiencing social isolation and loneliness (SIL) are at an increased risk of more disease‐specific complications, the presence of comorbidities, and mortality. Interventions targeting SIL may be of benefit in this population, though research in this field is limited.
Ghada Alsultany +3 more
wiley +1 more source
Predictive role of lactate dehydrogenase-to-albumin ratio (LAR) in nonalcoholic fatty liver disease and advanced liver fibrosis. [PDF]
Li G, He T, Geng M, Hong S, Qi F.
europepmc +1 more source
ABSTRACT Background Pharmacotherapy offers a potential solution for individuals with overweight and obesity to decrease their body weight. However, there is limited knowledge of the effects of antiobesity agents on the distribution of body fat. Methods The PubMed, Embase, and Cochrane Library databases were reviewed for randomized controlled trials ...
Xiuqi Qiao +4 more
wiley +1 more source
Lactate Dehydrogenase Inhibition Reverts the Fatty Acid‐Induced Neurotoxic Phenotype of Astrocytes
ALS models display increased LD accumulation. LD accumulation is linked to a neurotoxic phenotype in astrocytes. Lactate dehydrogenase inhibition reverts LD accumulation in ALS astrocytes. ABSTRACT Astrocytes are central to lipid metabolism in the central nervous system.
Daniel Esteve +5 more
wiley +1 more source
Response to the Comment on "Development and Validation of a Machine Learning-Based Marker for Early Detection and Prognosis Stratification of Nonalcoholic Fatty Liver Disease". [PDF]
Xiao L, Zeng L, Wang J, Hong C, Liu L.
europepmc +1 more source
Human Cyclophilins—An Emerging Class of Drug Targets
ABSTRACT Cyclophilins are a family of enzymes with peptidyl‐prolyl isomerase activity found in all cells of all organisms. To date, 17 cyclophilin isoforms have been identified in the human body, participating in diverse biological processes. Consequently, cyclophilins have emerged as promising targets for drug development to address a wide array of ...
Katarina Jurkova +3 more
wiley +1 more source
Influence of an internet-based proactive follow-up management model on the prognosis of nonalcoholic fatty liver disease. [PDF]
Liu SY, Gao GF, Wang XY, Yu J.
europepmc +1 more source

